Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells.
Mitwasi N, Feldmann A, Bergmann R, Berndt N, Arndt C, Koristka S, Kegler A, Jureczek J, Hoffmann A, Ehninger A, Cartellieri M, Albert S, Rossig C, Ehninger G, Pietzsch J, Steinbach J, Bachmann M. Mitwasi N, et al. Among authors: berndt n. Oncotarget. 2017 Sep 18;8(65):108584-108603. doi: 10.18632/oncotarget.21017. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312553 Free PMC article.
From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo.
Albert S, Arndt C, Koristka S, Berndt N, Bergmann R, Feldmann A, Schmitz M, Pietzsch J, Steinbach J, Bachmann M. Albert S, et al. Among authors: berndt n. Oncotarget. 2018 May 22;9(39):25597-25616. doi: 10.18632/oncotarget.25390. eCollection 2018 May 22. Oncotarget. 2018. PMID: 29876011 Free PMC article.
"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells.
Mitwasi N, Feldmann A, Arndt C, Koristka S, Berndt N, Jureczek J, Loureiro LR, Bergmann R, Máthé D, Hegedüs N, Kovács T, Zhang C, Oberoi P, Jäger E, Seliger B, Rössig C, Temme A, Eitler J, Tonn T, Schmitz M, Hassel JC, Jäger D, Wels WS, Bachmann M. Mitwasi N, et al. Among authors: berndt n. Sci Rep. 2020 Feb 7;10(1):2141. doi: 10.1038/s41598-020-59082-4. Sci Rep. 2020. PMID: 32034289 Free PMC article.
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells.
Arndt C, Loureiro LR, Feldmann A, Jureczek J, Bergmann R, Máthé D, Hegedüs N, Berndt N, Koristka S, Mitwasi N, Fasslrinner F, Lamprecht C, Kegler A, Hoffmann A, Bartsch T, Köseer AS, Egan G, Schmitz M, Hořejší V, Krause M, Dubrovska A, Bachmann M. Arndt C, et al. Among authors: berndt n. Oncoimmunology. 2020 Apr 5;9(1):1743036. doi: 10.1080/2162402X.2020.1743036. eCollection 2020. Oncoimmunology. 2020. PMID: 32426176 Free PMC article.
Theranostic CAR T cell targeting: A brief review.
Arndt C, Bachmann M, Bergmann R, Berndt N, Feldmann A, Koristka S. Arndt C, et al. Among authors: berndt n. J Labelled Comp Radiopharm. 2019 Jun 30;62(8):533-540. doi: 10.1002/jlcr.3727. Epub 2019 Jun 6. J Labelled Comp Radiopharm. 2019. PMID: 30889625 Review.
173 results